The neuropsychiatry of neuroacanthocytosis syndromes

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 5, 2011, Pages 1275-1283

  Walterfang, Mark ^a,b   Evans, Andrew ^a   Looi, Jeffrey Chee Leong ^c   Jung, Hans H ^e   Danek, Adrian ^f   Walker, Ruth H ^d   Velakoulis, Dennis ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c The Australian National University   (Australia)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chorea acanthocytosis; Executive impairment; McLeod syndrome; Neuroacanthocytosis; Obsessive compulsive disorder; Schizophrenia; Striatum

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRIFLUOPERAZINE;

ADJUVANT THERAPY; ANTICHOLINERGIC SYNDROME; BASAL GANGLION; BRAIN DEPTH STIMULATION; CHOREA; CHROMOSOME 16Q; CHROMOSOME 9Q; COGNITIVE DEFECT; CORPUS STRIATUM; DEPRESSION; DISEASE PREDISPOSITION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DYSKINESIA; DYSTONIA; EXECUTIVE FUNCTION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GLOBUS PALLIDUS; HUMAN; HUNTINGTON DISEASE LIKE SYNDROME; MAJOR DEPRESSION; MCLEOD SYNDROME; NEUROACANTHOCYTOSIS; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SUBTHALAMIC NUCLEUS;

BRAIN; HUMANS; MENTAL DISORDERS; NEUROACANTHOCYTOSIS; NEUROPSYCHIATRY;

EID: 79952537096     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.01.001     Document Type: Review

References (114)

1. Al-Asmi A., Jansen A.C., Badhwar A., Dubeau F., Tampieri D., Shustik C., Mercho S., Savard G., Dobson-Stone C., Monaco A.P., Andermann F., Andermann E. Familial temporal lobe epilepsy as a presenting feature of choreoacanthocytosis. Epilepsia 2005, 46:1256-1263.
2. Alexander G., de Long M., Strick P. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
3. Alheld G., Himer L., Switzer R. Basal ganglia. The Human Nervous System 1990, 483-582. Academic Press, New York. G. Paxinos (Ed.).
4. Angelini L., Nardocci N., Rumi V., Zorzi C., Strada L., Savoiardo M. Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life. J. Neurol. 1992, 239:417-425.
5. Aouizerate B., Guehl D., Cuny E., Rougier A., Bioulac B., Tignol J., Burbaud P. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog. Neurobiol. 2004, 72:195-221.
6. Appleby B.S., Duggan P.S., Regenberg A., Rabins P.V. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov. Disord. 2007, 22:1722-1728.
7. Arawaka S., Saito Y., Murayama S., Mori H. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology 1998, 51:887-889.
8. Bardien S., Abrahams F., Soodyall H., van der Merwe L., Greenberg J., Brink T., Carr J. A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Mov. Disord. 2007, 22:2083-2089.
9. Bassen F., Kornzweig A. Malformation of the erythrocytes in a case of atypical retinitis pigmentosa. Blood 1950, 5:381-387.
10. Bloch M.H., McGuire J., Landeros-Weisenberger A., Leckman J.F., Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol. Psychiatry 2010, 15:850-855.
11. Bohlega A.A., Dobson-Stone A.-J., Rampoldi C., Saha L., Murad P., Kareem H., Roberts A., Monaco G.A. Chorea-acanthocytosis: clinical and genetic findings in three families from the Arabian peninsula. Mov. Disord. 2003, 18:403-407.
12. Bonelli R., Cummings J. Frontal-subcortical circuitry and behavior. Dialog. Clin. Neurosci. 2007, 9:141-151.
13. Bottas A., Cooke R.G., Richter M.A. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?. J. Psychiatry Neurosci. 2005, 30:187-193.
14. Brin M.A.H., Symmans W., Marsh W., Rowland L. Neuropathology of McLeod phenotype is like chorea-acanthocytosis. Can. J. Neuro Sci. 1993, 20:S234.
15. Bronstein J.M., Tagliati M., Alterman R.L., Lozano A.M., Volkmann J., Stefani A., Horak F.B., Okun M.S., Foote K.D., Krack P., Pahwa R., Henderson J.M., Hariz M.I., Bakay R.A., Rezai A., Marks W.J., Moro E., Vitek J.L., Weaver F.M., Gross R.E., Delong M.R. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch. Neurol. 2010.
16. Bruneau M., Lesperance P., Chouinard S. Schizophrenia-like presentation of neuroacanthocytosis. J. Neuropsychiatry Clin. Neurosci. 2003, 15:378-380.
17. Burbaud P., Rougier A., Ferrer X., Guehl D., Cuny E., Arne P., Gross C., Bioulac B. Improvement of severe trunk spasms by bilateral high-frequency stimulation of the motor thalamus in a patient with chorea-acanthocytosis. Mov. Disord. 2002, 17:204-207.
18. Burbaud P., Vital A., Rougier A., Bouillot S., Guehl D., Cuny E., Ferrer X., Lagueny A., Bioulac B. Minimal tissue damage after stimulation of the motor thalamus in a case of chorea-acanthocytosis. Neurology 2002, 59:1982-1984.
19. Cavedini P., Gorini A., Bellodi L. Understanding obsessive-compulsive disorder: focus on decision-making. Neuropsychol. Rev. 2006, 16:3-15.
20. Chamberlain S., Blackwell A., Fineberg N., Robbins T., Sahakian B. The neuropsychology of obsessive-compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci. Biobehav. Rev. 2005, 29:399-419.
21. Cooper G., Rizzo M., Jones R. Adult-onset Hallervorden-Spatz syndrome presenting as cortical dementia. Alzheimer Dis. Assoc. Disord. 2000, 14:120-126.
22. Critchley E., Clark D., Wikler A. An adult form of acanthocytosis. Trans. Am. Neurol. Assoc. 1967, 92:132-137.
23. Critchley E., Betts J., Nicholson J., Weatherall D. Acanthocytosis, normolipoproteinemia and multiple tics. Postgrad. Med. J. 1970, 46:697-701.
24. Cummings J. Frontal-subcortical circuits and human behavior. Arch. Neurol. 1993, 50:873-880.
25. Danek A., Uttner I., Vogl T., Tatsch K., Witt T. Cerebral involvement in McLeod syndrome. Neurology 1994, 44:117-120.
26. Danek A., Rubio J.P., Rampoldi L., Ho M., Dobson-Stone C., Tison F., Symmans W.A., Oechsner M., Kalckreuth W., Watt J.M., Corbett A.J., Hamdalla H.H., Marshall A.G., Sutton I., Dotti M.T., Malandrini A., Walker R.H., Daniels G., Monaco A.P. McLeod neuroacanthocytosis: genotype and phenotype. Ann. Neurol. 2001, 50(6):755-764.
27. Danek A., Tierney M., Sheesley L., Grafman J. Cognitive findings in patients with chorea-acanthocytosis. Mov. Disord. 2001, 16:S30.
28. Danek A., Sheesley L., Tierney M., Uttner I., Grafman J. Cognitive and neuropsychiatric findings in McLeod syndrome and in chorea-acanthocytosis. Neuroacanthocytosis Syndromes 2004, 95-116. Springer, Dordrecht. 1st ed. A. Danek (Ed.).
29. Danek A., Jung H., Melone M., Rampoldi L., Broccoli V., Walker R. Neuroacanthocytosis: new developments in a neglected group of dementing disorders. J. Neurol. Sci. 2005, 229/230:171-186.
30. Dobson-Stone C., Danek A., Rampoldi L., Hardie R.J., Chalmers R.M., Wood N.W., Bohlega S., Dotti M.T., Federico A., Shizuka M., Tanaka M., Watanabe M., Ikeda Y., Brin M., Goldfarb L.G., Karp B.I., Mohiddin S., Fananapazir L., Storch A., Fryer A.E., Maddison P., Sibon I., Trevisol-Bittencourt P.C., Singer C., Caballero I.R., Aasly J.O., Schmierer K., Dengler R., Hiersemenzel L.P., Zeviani M., Meiner V., Lossos A., Johnson S., Mercado F.C., Sorrentino G., Dupré N., Rouleau G.A., Volkmann J., Arpa J., Lees A., Geraud G., Chouinard S., Németh A., Monaco A.P. Mutational spectrum of the CHAC gene in patients with choreoacanthocytosis. Eur. J. Hum. Genet. 2002, 10(11):773-781.
31. Dobson-Stone C., Velayos-Baeza A., Filippone L., Westbury S., Storch A., Erdmann T., Wroe S., Leenders K., Lang A., Dotti M., Federico A., Mohiddin S., Fananapazir L., Daniels G., Danek A., Monaco A. Chorein detection for the diagnosis of chorea-acanthocytosis. Ann. Neurol. 2004, 56:299-302.
32. Dooling E., Schoene W., Richardson E.J. Hallervorden-Spatz syndrome. Arch. Neurol. 1974, 30:70-83.
33. Dotti M., Battisti C., Malandrini A., Federico A., Rubio J., Circiarello G., Monaco A. McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene. Mov. Disord. 2000, 15:1282-1284.
34. Dydak U., Mueller S., Sandor P., Meier D., Boesiger P., Jung H. Cerebral metabolic alterations in McLeod syndrome. Eur. Neurol. 2006, 56:17-23.
35. Fernandez H., Friedman J. The role of atypical antipsychotics in the treatment of movement disorders. CNS Drugs 1999, 11:467-483.
36. Freeman K., Gregory A., Turner A., Blasco P., Hogarth P., Hayflick S. Intellectual and adaptive behaviour functioning in pantothenate kinase-associated neurodegeneration. J. Intell. Disabil. Res. 2007, 51:417-426.
37. Gold M.M., Shifteh K., Bello J.A., Lipton M., Kaufman D.M., Brown A.D. Chorea-acanthocytosis: a mimicker of Huntington disease case report and review of the literature. Neurologist 2006, 12:327-329.
38. Gouider-Khouja N., Miladi N., Belal S., Hentati F. Intrafamilial phenotypic variability of Hallervorden-Spatz syndrome in a Tunisian family. Parkinsonism Relat. Dis. 2000, 6:175-179.
39. Grahn J., Parkinson J., Owen A. The cognitive functions of the caudate nucleus. Prog. Neurobiol. 2008, 86:141-155.
40. Graybiel A., Kimura M. Adaptive neural networks in the basal ganglia. Models of Information Processing in the Basal Ganglia 1995, 103-116. MIT Press, Cambridge, MA. J. Houk, J. Davis, D. Beiser (Eds.).
41. Guehl D., Cuny E., Tison F., Benazzouz A., Bardinet E., Sibon Y., Ghorayeb I., Yelnick J., Rougier A., Bioulac B., Burbaud P. Deep brain pallidal stimulation for movement disorders in neuroacanthocytosis. Neurology 2007, 68:160-161.
42. Habermeyer B., Fuhr P., Hiss B., Alber C., Müller-Spahn F. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. Pharmacopsychiatry 2006, 39:193-194.
43. Hardie R.J., Pullon H.W., Harding A.E., Owen J.S., Pires M., Daniels G.L., Imai Y., Misra V.P., King R.H., Jacobs J.M., et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 1991, 114(Pt 1A):13-49.
44. Hayflick S.J., Westaway S.K., Levinson B., Zhou B., Johnson M.A., Ching K.H., Gitschier J. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N. Engl. J. Med. 2003, 348:33-40.
45. Henkel K., Walterfang M., Velakoulis D., Danek A., Kassubek J. Volumetric imaging in chorea-acanthocytosis. Neuroacanthocytosis Syndromes 2007, Springer, Dordecht. 2nd ed. A. Danek, R. Walker, S. Saiki (Eds.).
46. Hewer E., Danek A., Schoser B., Miranda M., Reichard R., Castiglioni C., Oechsner M., Goebel H., Heppner F., Jung H. McLeod myopathy revisited: more neurogenic and less benign. Brain 2007, 130:3285-3296.
47. Holmes S.E., O'Hearn E., Rosenblatt A., Callahan C., Hwang H.S., Ingersoll-Ashworth R.G., Fleisher A., Stevanin G., Brice A., Potter N.T., Ross C.A., Margolis R.L. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet. 2001, 29:377-378.
48. Ichiba M., Nakamura M., Kusumoto A., Mizuno E., Kurano Y., Matsuda M., Kato M., Agemura A., Tomemori Y., Muroya S., Nakabeppu Y., Sano A. Clinical and molecular genetic assessment of a chorea-acanthocytosis pedigree. J. Neurol. Sci. 2007, 263:124-132.
49. Jung H., Haker H. Schizophrenia as a manifestation of X-linked McLeod-neuroacanthocytosis syndrome. J. Clin. Psychiatry 2004, 65:722-723.
50. Jung H., Hergersberg M., Kneifel S., Alkadhi H., Schiess R., Weigell-Weber M., Daniels G., Kollias S., Hess K. McLeod syndrome: a novel mutation, predominant psychiatric manifestions, and distinct striatal imaging findings. Ann. Neurol. 2001.
51. Kartsounis L., Hardie R. The pattern of cognitive impairments in neuroacanthocytosis. Arch. Neurol. 1996, 53:77-80.
52. Kennedy R., Mittal D., O'Jile J. Electroconvulsive therapy in movement disorders: an update. J. Neuropsychiatry Clin. Neurosci. 2003, 15:407-421.
53. Kimura M., Matsumoto N. Neuronal activity in the basal ganglia. Functional implications. Adv. Neurol. 1997, 74:111-118.
54. Komossa K., Depping A.M., Gaudchau A., Kissling W., Leucht S. Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst. Rev. 2010, 12:CD008121.
55. Levine I., Yettra M., Stefanini M. A hereditary neurological disorder with acanthocytosis. Neurology 1960, 10:425.
56. Levine I., Estes J., Looney J. Hereditary neurological disease with acanthocytosis, a new syndrome. Arch. Neurol. 1967, 19:403-409.
57. Lossos A., Dobson-Stone C., Monaco A., Soffer D., Rahamim E., Newman J., Mohiddin S., et al. Early clinical heterogeneity in choreoacanthocytosis. Arch. Neurol. 2005, 62:611-614.
58. Mallet L., Polosan M., Jaafari N., Baup N., Welter M.L., Fontaine D., du Montcel S.T., Yelnik J., Chereau I., Arbus C., Raoul S., Aouizerate B., Damier P., Chabardes S., Czernecki V., Ardouin C., Krebs M.O., Bardinet E., Chaynes P., Burbaud P., Cornu P., Derost P., Bougerol T., Bataille B., Mattei V., Dormont D., Devaux B., Verin M., Houeto J.L., Pollak P., Benabid A.L., Agid Y., Krack P., Millet B., Pelissolo A. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N. Engl. J. Med. 2008, 359:2121-2134.
59. Marelli C., Piacentini S., Garavaglia B., Girotti F., Albanese A. Clinical and neuropsychological correlates in two brothers with pantothenate kinase-associated neurodegeneration. Mov. Disord. 2005, 20:208-212.
60. Margolis R., O'Hearn E., Rosenblatt A., Willour V., Holmes S., Franz M., Callahan C., Hwang H., Troncoso J., Ross C. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann. Neurol. 2001, 50:373-380.
61. Margolis R.L., Holmes S.E., Rosenblatt A., Gourley L., O'Hearn E., Ross C.A., Seltzer W.K., Walker R.H., Ashizawa T., Rasmussen A., Hayden M., Almqvist E.W., Harris J., Fahn S., MacDonald M.E., Mysore J., Shimohata T., Tsuji S., Potter N., Nakaso K., Adachi Y., Nakashima K., Bird T., Krause A., Greenstein P. Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann. Neurol. 2004, 56.
62. Margolis R.L., Holmes S.E., Rosenblatt A., Gourley L., O'Hearn E., Ross C.A., Seltzer W.K., Walker R.H., Ashizawa T., Rasmussen A., Hayden M., Almqvist E.W., Harris J., Fahn S., MacDonald M.E., Mysore J., Shimohata T., Tsuji S., Potter N., Nakaso K., Adachi Y., Nakashima K., Bird T., Krause A., Greenstein P. Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann. Neurol. 2004, 56:670-674.
63. Miranda M., Castiglioni C., Frey B., Hergersberg M., Danek A., Jung H. Phenotypic variability of a distinct deletion in McLeod syndrome. Mov. Disord. 2007, 22:1358-1361.
64. Morphy M., Feldman J., Kilburn G. Hallervorden-Spatz disease in a psychiatric setting. J. Clin. Psychiatry 1989, 50:66-68.
65. Müller-Vahl K., Berding G., Emrich H., Peschel T. Chorea-acanthocytosis in monozygotic twins: clinical findings and neuropathological changes as detected by diffusion tensor imaging, FDG-PET and 123I-b-CIT-SPECT. J. Neurol. 2007, 254:1081-1088.
66. Nardocci N., Rumi V., Combi M., Angelini L., Mirabile D., Bruzzone M. Complex tics, stereotypies, and compulsive behavior as clinical presentation of a juvenile progressive dystonia suggestive of Hallervorden-Spatz disease. Mov. Disord. 1994, 9:369-371.
67. Nicholas A., Earnst K., Marson D. Atypical Hallervorden-Spatz disease with preserved cognition and obtrusive obsessions and compulsions. Mov. Disord. 2005, 20:880-886.
68. Oechsner M., Danek A., Winkler G. McLeod-Neuroakanthozytose: ein zu selten diagnostiziertes Syndrom?. Akt Neurol. 1996, 23:245-250.
69. Oechsner M., Buchert R., Beyer W., Danek A. Reduction of striatal glucose metabolism in McLeod chorea-acanthocytosis. J. Neurol. Neurosurg. Psychiatry 2001, 70:517-520.
70. Öner Ö., Öner P., Deda G., İçaĝasioĝlu D. Psychotic disorder in a case with Hallervorden-Spatz disease. Acta Psychiatr. Scand. 2003, 108:394-397.
71. Pantelis C., Barnes T., Nelson H. Is the concept of frontal-subcortical dementia relevant to schizophrenia?. Br. J. Psychiatry 1992, 160:442-460.
72. Pantelis C., Barnes T.R., Nelson H.E., Tanner S., Weatherley L., Owen A.M., Robbins T.W. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997, 120(Pt 10):1823-1843.
73. Parent A., Hazrati L. Anatomical aspects of information processing in primate basal ganglia. Trends Neurosci. 1993, 16:111-116.
74. Pellecchia M., Valente E., Cif L., Salvi S., Albanese A., Scarano V., Bonuccelli U., Bentivoglio A., D'Amico P., Marelli C., Di Giorgio A., Coubes P., Barone P., Dallapiccola B. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology 2005, 64:1810-1812.
75. Rampoldi L., Dobson-Stone C., Rubio J., Danek A., Chalmers R., Wood N., Verellen C., Ferrer X., Malandrini A., Fabrizi G., Brown R., Vance J., Pericak-Vance M., Rudolf G., Carre S., Alonso E., Manfredi M., Nemeth A., Monaco A. A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat. Genet. 2001, 28:119-120.
76. Rampoldi L., Danek A., Monaco A.P. Clinical features and molecular bases of neuroacanthocytosis. J. Mol. Med. 2002, 80:475-491.
77. Rinne J., Daniel S., Scaravilli F., Pires M., Harding A., Marsden C. The neuropathological features of neuroacanthocytosis. Mov. Disord. 1994, 9:297-304.
78. Robbins T.W. The case of frontostriatal dysfunction in schizophrenia. Schizophr. Bull. 1990, 16:391-402.
79. Robertson B., Evans A., Walterfang M., Ng A., Velakoulis D. Epilepsy, progessive movement disorder and cognitive decline. J. Clin. Neurosci. 2008, 15:812.
80. Rodrigues G.G.R., Walker R.H., Brice A., Cazeneuve C., Russaouen O., Teive H.A.G., Munhoz R.P., Becker N., Raskin S., Werneck L.C., Junior W.M., Tumas V. Huntington's disease-like 2 in Brazil-report of 4 patients. Mov. Disord. 2008, 23:2244-2247.
81. Rodrigues G., Walker R., Bader B., Danek A., Marques W., Tumas V. Chorea-acanthocytosis: report of two Brazilian cases. Mov. Disord. 2009, 23:2090-2093.
82. Rosenblatt A., Leroi I. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics 2000, 41:24-30.
83. Rudnicki D., Pletnikova O., Vonsattel J., Ross C., Margolis R. A comparison of Huntington disease and Huntington disease-like 2 neuropathology. J. Neuropathol. Exp. Neurol. 2008, 67:366-374.
84. Ruiz P.J., Ayerbe J., Bader B., Danek A., Sainz M.J., Cabo I., Frech F.A. Deep brain stimulation in chorea acanthocytosis. Mov. Disord. 2009, 24:1546-1547.
85. Sachdev P., Malhi G. Obsessive-compulsive behaviour: a disorder of decision-making. Aust. N.Z. J. Psychiatry 2005, 39:757-763.
86. Sachin S., Goyal V., Singh S., Shukla G., Sharma M., Gaikwed S., Behari M. Clinical spectrum of Hallervorden-Spatz syndrome in India. J. Clin. Neurosci. 2009, 16:253-258.
87. Saiki S., Hirose G., Sakai K., Matsunari I., Higashi K., Saiki M., Kataoka S., Hori A., Shimazaki K. Chorea-acanthocytosis associated with Tourettism. Mov. Disord. 2004, 19:833-836.
88. Sakai T., Iwashita H., Kakugawa M. Neuroacanthocytosis syndrome and choreo-acanthocytosis (Levine-Critchley syndrome). Neurology 1985, 35:1679.
89. Savoiardo M., Halliday W.C., Nardocci N., Strada L., D'Incerti L., Angelini L., Rumi V., Tesoro-Tess J.D. Hallervorden-Spatz disease: MR and pathologic findings. Am. J. Neuroradiol. 1993, 14:155-162.
90. Scarano V., Pellecchia M., Filla A., Barone P. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome. Mov. Disord. 2002, 17:618-620.
91. Scheid R., Bader B., Ott D.V., Merkenschlager A., Danek A. Development of mesial temporal lobe epilepsy in chorea-acanthocytosis. Neurology 2009, 73:1419-1422.
92. Sorrentino G., De Renzo A., Miniello S., Nori O., Bonavita V. Late appearance of acanthocytes during the course of chorea-acanthocytosis. J. Neurol. Sci. 1999, 175-178.
93. Spitz M., Jankovic J., Killian J. Familial tic disorder, parkinsonism, motor neuron disease, and acanthocytosis: a new syndrome. Neurology 1985, 35:366-370.
94. Stevanin G., Fujigasaki H., Lebre A.-S., Camuzat A., Jeannequin C., Dode C., Takahashi J., San C., Bellance R., Brice A., Durr A. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 2003, 126:1599-1603.
95. Storch A., Kornhass M., Schwarz J. Testing for acanthocytosis-A prospective reader-blinded study in movement disorder patients. J. Neurol. 2005, 252:84-90.
96. Sunwoo Y.K., Lee J.S., Kim W.H., Shin Y.B., Lee M.J., Cho I.H., Ock S.M. Psychiatric disorder in two siblings with Hallervorden-Spatz disease. Psychiatry Invest. 2009, 6:226-229.
97. Swerdlow N., Koob G. Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav. Brain Res. 1987, 10:215-217.
98. Takahashi Y., Kojima T., Atsumi Y., Okubo Y., Shimazono Y. Case of chorea-acanthocytosis with various psychotic symptoms. Psychiatr. Neurol. Jpn. 1983, 85:457-472.
99. Takashima H., Sakai T., Iwashita H., Matsuda Y., Tanaka K., Oda K., Okubo Y., Reid M. A family of McLeod syndrome, masquerading as chorea-acanthocytosis. J. Neurol. Sci. 1994, 124:56-60.
100. Tekin S., Cummings J. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J. Psychosom. Res. 2002, 53:647-654.
101. Thomas M., Hayflick S., Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov. Disord. 2003, 19:36-42.
102. Ueno S., Maruki Y., Nakamura M., Tomemori Y., Kamae K., Tanabe H., Yamashita Y., Matsuda S., Kaneko S., Sano A. The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat. Genet. 2001, 28:121-122.
103. Vazquez M., Martinez M. Electroconvulsive therapy in neuroacanthocytosis or McLeod syndrome. J. ECT 2009, 25:72-73.
104. Walker R.H., Jankovic J., O'Hearn E., Margolis R.L. Phenotypic features of Huntington's disease-like 2. Mov. Disord. 2003, 18:1527-1530.
105. Walker R.H., Rasmussen A., Rudnicki D., Holmes S.E., Alonso E., Matsuura T., Ashizawa T., Davidoff-Feldman B., Margolis R.L. Huntington's disease-like 2 can present as chorea-acanthocytosis. Neurology 2003, 61:1002-1004.
106. Walker R., Liu Q., Ichiba M., Muroya S., Nakamura M., Sano A., Kennedy C., Sclar G. Self-mutilation in chorea-acanthocytosis: manifestation of movement disorder or psychopathology?. Mov. Disord. 2006, 21:2268-2269.
107. Walker R., Jung H., Dobson-Stone C., Rampoldi L., Sano A., Tison F., Danek A. Neurologic phenotypes associated with acanthocytosis. Neurology 2007, 68:92-98.
108. Walterfang M., Yucel M., Walker R., Evans A., Bader B., Ng A., Danek A., Mocellin R., Velakoulis D. Adolescent obsessive compulsive disorder heralding chorea-acanthocytosis. Mov. Disord. 2008, 23:422-425.
109. Walterfang M., Evans A., Velakoulis D. Psychiatric aspects of the neurodegenerative choreas. The Differential Diagnosis of Chorea 2010, Oxford University Press, New York. R. Walker (Ed.).
110. Walterfang, M., Looi, J., Styner, M., Walker, R., Danek, A., Niethammer, M., Evans, A., Kotschet, K., Rodrigues, G., Hughes, A., Velakoulis, D., Shape alterations in the striatum in chorea-acanthocytosis. Psychiatry Res. Neuroimaging, in press.
111. Yamada H., Ohji T., Sakurai S., Yamaguchi E., Uchimura N., Morita K., Yamada S. Chorea-acanthocytosis presenting with schizophrenia symptoms as first symptoms. Psychiatry Clin. Neurosci. 2009, 63:253-254.
112. Zarranz J.J., Gomez-Esteban J.C., Atares B., Lezcano E., Forcadas M. Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome. Mov. Disord. 2006, 21:107-111.
113. Zeman A., Daniels G., Tilley L., Dunn M., Toplis L., Bullock T., Poole J., Blackwood D. McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene. Psychiatr. Genet. 2005, 15:291-293.
114. Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gitschier J., Hayflick S.J. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 2001, 28:345-349.